Science & Enterprise subscription

Follow us on Twitter

  • Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were high… https://t.co/oLdLmHGz1M
    about 19 hours ago
  • New post on Science and Enterprise: Venture Funds, Mergers in A.I. Up Sharply in 2018 https://t.co/rimak87tjS #Science #Business
    about 19 hours ago
  • Wish it weren't needed, but ... https://t.co/SZAb2GO2vz
    about 3 days ago
  • The Edelman public relations agency released results of a survey earlier this month gauging the public's awareness… https://t.co/XaxxGJOYQl
    about 3 days ago
  • New post on Science and Enterprise: Infographic – Public, Tech Execs Differ on A.I. Use https://t.co/cvVj3IyCR0 #Science #Business
    about 3 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

NIH Funding Nanodrugs to Prevent Opioid Addiction

Head in hands

A drug that invokes the immune system to block addictive effects of opioid pain drugs and heroin is in early development at Washington University in St. Louis. . . . → Read More: NIH Funding Nanodrugs to Prevent Opioid Addiction

Gates Supporting Infectious Antibody Discovery

Human B-cell

The Bill and Melinda Gates Foundation is enlisting a company that discovers therapeutic antibodies to help researchers develop new drugs and vaccines for serious infectious diseases. . . . → Read More: Gates Supporting Infectious Antibody Discovery

Microsoft, Biotech Partner on Gene, Cell Therapies

Computational biology illustration

A biotechnology company in the U.K. and U.S. software maker Microsoft are collaborating on new processes to speed development of gene and cell therapies. . . . → Read More: Microsoft, Biotech Partner on Gene, Cell Therapies

Trial Shows Engineered Plant Product Heals Wounds

Tobacco plants

A small-scale clinical trial shows synthetic human collagen derived from engineered tobacco plants promotes closure of lower-limb wounds, often difficult to heal. . . . → Read More: Trial Shows Engineered Plant Product Heals Wounds

Commentary – Scott Gottlieb’s Legacy

Scott Gottlieb

During his tenure, FDA issued a number of guidance documents outlining regulatory processes and practices that streamline reviews, yet are still dictated by scientific evidence. . . . → Read More: Commentary – Scott Gottlieb’s Legacy

Trial Testing Targeted Solid Tumor Immunotherapy

Alligator head

A clinical trial is underway testing the safety of a cancer therapy that harnesses the immune system, but also works only in the tumor to reduce adverse side effects. . . . → Read More: Trial Testing Targeted Solid Tumor Immunotherapy

Skin Bacteria Therapy Tested in Kids with Eczema

Child with atopic dermatitis

A clinical trial is underway testing a form of bacteria sprayed on the skin that oxidize ammonia as a treatment for atopic dermatitis, or eczema, in children and teens. . . . → Read More: Skin Bacteria Therapy Tested in Kids with Eczema

Biogen Acquires Gene Therapy Company in $800M Deal

Eye exam

A company developing treatments for inherited eye diseases that replace malfunctioning with healthy genes is being acquired by biotechnology company Biogen. . . . → Read More: Biogen Acquires Gene Therapy Company in $800M Deal

Anti-Inflammatory Human Protein Produced in Plants

Researchers in Canada genetically engineered tobacco plants to economically produce large quantities of a human protein with anti-inflammatory properties. . . . → Read More: Anti-Inflammatory Human Protein Produced in Plants

Trials Underway Testing Crispr for Blood Disorders

Crispr genome edits illustration

Clinical trials testing the genome editing technique Crispr for sickle cell disease and beta thalassemia, two inherited blood disorders, enrolled and infused their first patients. . . . → Read More: Trials Underway Testing Crispr for Blood Disorders